Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Other Accumulated Expenses: 2013-2025

Historic Other Accumulated Expenses for MediWound (MDWD) over the last 12 years, with Sep 2025 value amounting to $3.7 million.

  • MediWound's Other Accumulated Expenses rose 39.19% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 39.19%. This contributed to the annual value of $3.6 million for FY2024, which is 8.61% down from last year.
  • MediWound's Other Accumulated Expenses amounted to $3.7 million in Q3 2025, which was up 9.80% from $3.4 million recorded in Q2 2025.
  • MediWound's 5-year Other Accumulated Expenses high stood at $5.2 million for Q1 2021, and its period low was $2.7 million during Q3 2024.
  • For the 3-year period, MediWound's Other Accumulated Expenses averaged around $3.4 million, with its median value being $3.5 million (2024).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first slumped by 40.93% in 2022, then skyrocketed by 39.19% in 2025.
  • Quarterly analysis of 5 years shows MediWound's Other Accumulated Expenses stood at $3.6 million in 2021, then grew by 14.89% to $4.2 million in 2022, then decreased by 6.44% to $3.9 million in 2023, then declined by 8.61% to $3.6 million in 2024, then spiked by 39.19% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.4 million for Q2 2025, and $3.3 million during Q1 2025.